Augusta Biomedical Research Corporation (EIN 581857974) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1989

Legal Domicile

Phone

7068233933

Tax Period

2025-01-01 to 2025-12-31

Augusta Biomedical Research Corporation, founded in 1989, is a small nonprofit that reported $181K in total revenue in fiscal year 2025. Revenue fell 37% from the prior year — a significant decline worth monitoring. Expenses of $245K exceeded revenue, resulting in a 35% operating deficit.

Mission

To advance the research and education missions of the Department of Veterans Affairs (VA), and specifically the Charlie Norwood VA Medical Center, Augusta, GA, through the support of research-related and education-related activities.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $178,442

Program Service Revenue $0

Investment Income $2,884

Other Revenue $0

TOTAL REVENUE $181,326

Expense Breakdown

Grants Paid $0

Salaries & Benefits $150,060

Fundraising Expenses $0

Program Expenses $119,412

Other Expenses $94,668

TOTAL EXPENSES $244,728

Year-over-Year Comparison

	2025	2024	Change
Revenue	$181,326	$289,012	-0.4%
Expenses	$244,728	$327,233	-0.3%
Net Income	$-63,402	$-38,221	+0.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Herimone Chappell MD	Board Member	2.00	Officer	$0	$0	$0
JG Long MBA	Board Member	2.00	Officer	$0	$0	$0
Oscar Rodriguez	Board Member	2.00	Officer	$0	$0	$0
Lovetta Ford	Board Member	2.00	Officer	$0	$0	$0
Amado Baez MD	Board Chair	2.00	Officer	$0	$0	$0
Constance Lavieri-Reynolds MD	Secretary	2.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$181,326	$244,728	$197,777	$-63,402
2024	$289,012	$327,233	$260,795	$-38,221
2023	$346,204	$356,045	$347,940	$-9,841
2022	$80,204	$152,847	$303,534	$-72,643
2021	$102,169	$134,917	$374,758	$-32,748
2020	$101,924	$169,988	$407,439	$-68,064
2019	$297,862	$359,966	$474,859	$-62,104
2018	$452,971	$410,323	$528,649	$42,648

Augusta Biomedical Research Corporation